Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...

Moderna (NASDAQ:MRNA) is obviously best known as a vaccine company, with much of its success in recent years owed to their COVID-19 vaccines. Of course, this isn't the only story they're working ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...

It also had plans to start filling doses of its COVID vaccine in the continent as early as 2023. However, Moderna has not received any vaccine orders for Africa since 2022 amid waning demand ...

Authors focused their research on those who received the COVID vaccine from Pfizer or Moderna and died within 100 days of receiving their shots. Only 40 deaths occurred in that window. Of the 40 ...

A new study found that states with a higher percentage of Republican voters are seeing more reports of adverse side effects from COVID-19 vaccines ... that a 10 percent increase in state-level ...